Citigroup’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Sell |
26,090
-31,556
| -55% | -$84.6K | ﹤0.01% | 3865 |
|
|
2025
Q1 | $81.3K | Sell |
57,646
-6,493
| -10% | -$9.16K | ﹤0.01% | 3939 |
|
|
2024
Q4 | $128K | Buy |
64,139
+5,237
| +9% | +$10.4K | ﹤0.01% | 3865 |
|
|
2024
Q3 | $186K | Buy |
58,902
+43,479
| +282% | +$137K | ﹤0.01% | 3626 |
|
|
2024
Q2 | $48.7K | Buy |
+15,423
| New | +$48.7K | ﹤0.01% | 3866 |
|
|
2023
Q3 | – | Sell |
-1,834
| Closed | -$3.94K | – | 4878 |
|
|
2023
Q2 | $3.94K | Buy |
+1,834
| New | +$3.94K | ﹤0.01% | 4485 |
|
|
2023
Q1 | – | Sell |
-38
| Closed | -$146 | – | 4710 |
|
|
2022
Q4 | $146 | Buy |
38
+7
| +23% | +$27 | ﹤0.01% | 4813 |
|
|
2022
Q3 | $0 | Sell |
31
-2
| -6% | – | ﹤0.01% | 4925 |
|
|
2022
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 5357 |
|
|
2022
Q1 | $0 | Buy |
33
+1
| +3% | – | ﹤0.01% | 5433 |
|
|
2021
Q4 | $1K | Buy |
+32
| New | +$1K | ﹤0.01% | 4963 |
|